Current Size: 100%


Below you find some of the most relevant publications from Florian Grebien. A complete list of publications can be found here.

Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A, Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu H, Dong A, Senisterra G, Stukalov A, Huber KV, Schönegger A, Marcellus R, Bilban M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C, Arrowsmith CH, Superti-Furga G (2015) Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. Nat Chem Biol. Aug;11(8):571-8.

Giambruno R*, Grebien F*, Stukalov A, Knoll C, Planyavsky M, Rudashevskaya EL, Colinge J, Superti-Furga G, Bennett KL (2013) Affinity Purification Strategies for Proteomic Analysis of Transcription Factor Complexes. J Proteome Res, Sep 6;12(9):4018-27. (equal contribution)

Hantschel O, Grebien F, Superti-Furga G (2012) The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL. Cancer Res, Oct 1; 72(19):4890-5.

Grebien F*, Hantschel O*, Wojcik J, Kaupe I, Kovacic B, Wyrzucki AM, Gish GD, Cerny-Reiterer S, Koide A, Beug H, Pawson T, Valent P, Koide S, Superti-Furga G (2011) Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell, Oct 14; 147(2):306-19. (equal contribution)

Kerenyi MA*, Grebien F*, Gehart H, Schifrer M, Artaker M, Kovacic B, Beug H, Moriggl R, Mullner EW (2008) Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood, Nov 1; 112(9):3878-88. (* equal contribution)

Grebien F, Kerenyi MA, Kovacic B, Kolbe T, Becker V, Dolznig H, Pfeffer K, Klingmueller U, Mueller M, Beug H, Mullner EW, Moriggl R (2008) Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood, May 1; 111(9):4511-22

Research Groups: